Riluzole pharmacokinetics in young patients with spinal muscular atrophy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Riluzole pharmacokinetics in young patients with spinal muscular atrophy

Published:2011-02-01 Issue:3 Volume:71 Page:403-410
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Abbara Chadi,Estournet Brigitte,Lacomblez Lucette,Lelièvre Benedicte,Ouslimani Amal,Lehmann Blandine,Viollet Louis,Barois Annie,Diquet Bertrand

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.2010.03843.x/fullpdf

Reference19 articles.

1. Epidemiology of spinal muscular atrophies in a sample of the Italian population;Mostacciuolo;Neuroepidemiology,1992

2. Phenotypic heterogeneity of spinal muscular atrophy mapping to chromosome 5q11.2-13.3 (SMA 5q);Munsat;Neurology,1990

3. Possible strategies for treatment of SMA patients: a neurobiologist's view;Greensmith;Neuromuscul Disord,1995

4. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group;Bensimon;N Engl J Med,1994

5. Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II;Lacomblez;Lancet,1996

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Therapeutic Options and Repurposed Drugs for Neurodegeneration;Advances in Diagnostics and Immunotherapeutics for Neurodegenerative Diseases;2024-07-28

2. Riluzole in Spinal Cord Injury Study (RISCIS)–Pharmacokinetic (PK) Sub-Study: An Analysis of Pharmacokinetics, Pharmacodynamics, and Impact on Axonal Degradation of Riluzole in Patients With Traumatic Cervical Spinal Cord Injury Enrolled in the RISCIS Phase III Randomized Controlled Trial;Journal of Neurotrauma;2023-09-01

3. In Search of a Cure: The Development of Therapeutics to Alter the Progression of Spinal Muscular Atrophy;Brain Sciences;2021-02-05

4. Drug treatment for spinal muscular atrophy types II and III;Cochrane Database of Systematic Reviews;2020-01-06

5. Drug treatment for spinal muscular atrophy type I;Cochrane Database of Systematic Reviews;2019-12-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3